Hypercalcemia of malignancy remains a clinically relevant problem.
作者信息
Van Poznak Catherine
机构信息
University of Michigan Comprehensive Cancer Center, Breast Oncology program, Ann Arbor, Michigan 48109-0942, USA.
出版信息
Cancer J. 2006 Jan-Feb;12(1):21-3. doi: 10.1097/00130404-200601000-00005.
Abstract
摘要
相似文献
1
Hypercalcemia of malignancy remains a clinically relevant problem.
Cancer J. 2006 Jan-Feb;12(1):21-3. doi: 10.1097/00130404-200601000-00005.
2
Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.硝酸镓与帕米膦酸盐用于急性控制癌症相关高钙血症的随机、双盲、II期试验。
Cancer J. 2006 Jan-Feb;12(1):47-53. doi: 10.1097/00130404-200601000-00009.
3
Hypercalcemia and gallium nitrate.
J Support Oncol. 2004 Nov-Dec;2(6):518-20.
4
Drug therapy of hypercalcemia due to malignancy.恶性肿瘤所致高钙血症的药物治疗
Recent Results Cancer Res. 1994;137:138-60. doi: 10.1007/978-3-642-85073-8_9.
5
[Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].唑来膦酸（择泰）治疗恶性肿瘤高钙血症的临床前及临床概况
Nihon Yakurigaku Zasshi. 2005 Nov;126(5):353-7. doi: 10.1254/fpj.126.353.
6
Hypercalcemia of malignancy.恶性肿瘤高钙血症
Semin Nephrol. 2004 Jan;24(1):48-54. doi: 10.1053/j.semnephrol.2003.08.015.
7
The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy.使用唑来膦酸，一种新型、高效的双膦酸盐，用于治疗恶性肿瘤引起的高钙血症。
Oncologist. 2002;7(6):481-91. doi: 10.1634/theoncologist.7-6-481.
8
Modern management of malignant hypercalcemia.恶性高钙血症的现代管理
Am J Hosp Palliat Care. 2011 Nov;28(7):515-7. doi: 10.1177/1049909111414164. Epub 2011 Jul 1.
9
Mismanagement of malignant hypercalcaemia.恶性高钙血症的管理不当。
Clin Med (Lond). 2013 Feb;13(1):118. doi: 10.7861/clinmedicine.13-1-118.
10
Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.顺铂作为唑来膦酸难治性高钙血症的一种有效治疗方法。
Ann Oncol. 2011 May;22(5):1244-1246. doi: 10.1093/annonc/mdr123. Epub 2011 Apr 2.
Zotero 插件